Indena SpA:企業の戦略的SWOT分析

◆英語タイトル:Indena SpA - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2861
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Indena SpA – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Indena SpA (Indena), a subsidiary of IdB Holding SpA is a provider of active ingredients. It identifies, develops and manufactures active principles derived from plants which find applications in pharmaceutical, health-food and personal care industries. It produces standardized extracts from plants, which are recognized to have therapeutic properties, and are proven to have pharmacological value. The company focuses on producing anti-cancer drugs in the area of pharmaceutical research. It also focuses on producing standardized botanical derivatives that form important ingredients in health food products. The company has sales operations across France, Brazil, the US, Japan and China; and production facilities in Italy, France and India. Indena is headquartered in Milan, Italy.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Indena SpA – Key Facts
Indena SpA – Key Employees
Indena SpA – Major Products and Services
Indena SpA – History
Indena SpA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Indena SpA – Business Description
Indena SpA – SWOT Analysis
SWOT Analysis – Overview
Indena SpA – Strengths
Indena SpA – Weaknesses
Indena SpA – Opportunities
Indena SpA – Threats
Indena SpA – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Indena SpA, Key Facts
Indena SpA, Key Employees
Indena SpA, Major Products and Services
Indena SpA, History
Indena SpA, Subsidiaries
Indena SpA, Key Competitors

★海外企業調査レポート[Indena SpA:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Park City Group Inc (PCYG):企業の財務・戦略的SWOT分析
    Summary Park City Group Inc (Park City) is a technology company that provides supply chain, merchandising and store level solutions. The company offers scan based trading, vendor managed inventory, DSD visibility and strategic analysis, distribution center procurement, store level replenishment, ent …
  • VisionQuest Biomedical LLC:製品パイプライン分析
    Summary VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include eyestar, DR-RACS, and neurotherm. Its eyestar product is a total eye disease screening program package; DR-RACS is an automated …
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • Torrent Power Ltd (TORNTPOWER):企業の財務・戦略的SWOT分析
    Torrent Power Ltd (TORNTPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • HSBC Holdings Plc:企業のM&A・事業提携・投資動向
    HSBC Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HSBC Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Enable Injections Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial …
  • Phoenix Global Resources Plc (PGR):石油・ガス:M&Aディール及び事業提携情報
    Summary Phoenix Global Resources Plc (Phoenix), formerly known as Andes Energia Plc, is an upstream oil and gas company. It conducts exploration, development and production of oil and gas for conventional and unconventional resources. It has diversified portfolio of oil and gas assets in Argentina. …
  • CRH Medical Corp (CRH):医療機器:M&Aディール及び事業提携情報
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp, is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H …
  • Genextra Spa-製薬・医療分野:企業M&A・提携分析
    Summary Genextra SpA (Genextra) is a pharmaceutical company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, mono therapy and diabetes, INT- 777 for metabolic syndrome; novel HDAC and HSP90 inhibitors for the treatment of cancer; mj …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • GlycoNex Inc (4168):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoNex Inc (GlycoNex) is a drug discovery company that conducts research and development in glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. The company carries out antibody drug development through its various technology platforms such as glyco …
  • Intercept Energy Services Inc (IES):石油・ガス:M&Aディール及び事業提携情報
    Summary Intercept Energy Services Inc (Intercept Energy), formerly Global Green Matrix Corp is an oilfield service firm that offers water heating services. The firm provides services such as oilfield services, energy extraction and related services, frac water heating, oil sands processing, and oilf …
  • Key Petroleum Ltd (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Key Petroleum Ltd (Key Petroleum) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company carries out projects such as Canning Basin and Perth Basin. It holds interest in exploration permits such as EP 438, EP 448, EP 104/ …
  • Spark Therapeutics Inc (ONCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • Autoliv, Inc.:企業の戦略・SWOT・財務情報
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Reece Ltd (REH):企業の財務・戦略的SWOT分析
    Reece Ltd (REH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆